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Background: Obstructive sleep apnea (OSA) has been associated with higher cardiovascular (CV) morbidity and mortality. Whether OSA severity is 
independently associated with changes in cardiac structure and function is unclear.
Methods: Participants in the Best Apnea Intervention in Research (BestAIR) trial with moderate to severe OSA and established CV disease or 
significant CV risk factors underwent echocardiography, polysomnography and 24 hour ambulatory BP monitoring (ABPM) at enrollment. We assessed 
the association between OSA severity measured by tertiles of the apnea hypopnea index (AHI) and conventional measures of cardiac structure and 
function and longitudinal strain for the left and right ventricles.
results: Among 140 subjects (age: 63.2±7.4; 66% men, AHI: 23.9 [17.2-33.4], ABPM: 124±13/72±8 mmHg),left ventricle mass indexed to height 
to allometric power of 2.7 was associated with AHI after multivariable adjustments, including ABPM (p=0.02). Results were stronger in those with 
CVD risk factors than established CVD. AHI was not associated with other echocardiographic measures of cardiac structure or function (Table).
conclusion: OSA severity appears to be associated with increased LV mass independent of ABPM. Underlying cardiac disease may modify this 
association.
Table: Echocardiographic measurements of cardiac structure and function by tertiles of AHI
1st tertile (N=47)
AHI: 6.7-18.5
2nd tertile (N=47)
AHI: 18.6-30.6
3rd tertile (N=46)
AHI: 30.7-108
P for trend*
LV morphology and function
LVEDD (cm) 4.3±0.4 4.5±0.5 4.5±0.5 0.014
LVEDV (ml) 106.8±20.3 116.7±19.4 113.5±19.0 0.40
RWT 0.47±0.07 0.48±0.09 0.48±0.09 0.95
LVMI (g/m2.7) 34.2±8.0 38.3±8.6 38.7±8.4 0.001†
LVEF (%) 61±3 60±4 60±6 0.31
LV LS (%) -18.8±3.1 -18.8±3.6 -18.8±3.4 0.68
LV diastolic function
LAVI (ml/m2.7) 11.1±2.8 12.2±4.0 12.0±4.2 0.35
E/E’ 7.8±2.3 7.7±2.4 8.4±2.7 0.18
RV morphology and function
RVEDA (cm2) 24.7±4.5 25.5±5.1 24.7±4.8 0.86
RVFAC (%) 47±5 48±4 47±5 0.30
TA S’ (m/s) 13.4±2.6 13.0±3.3 14.2±2.8 0.07
RV FWLS (%) -25.7±4.4 -24.2±5.4 -27.1±5.7 0.32
Estimation of Pulmonary Pressures
TR jet velocity (m/s) 2.4±0.3 2.5±0.2 2.5±0.2 0.50
LV: left ventricle; LVEDD: LV end diastolic diameter; LVEDV:LV end diastolic volume, RWT: relative wall thickness, LVMI: LV mass index, LVEF: LV ejection fraction; LV LS: LV longitudinal 
strain; LAVI: left atrium volume index; E/E’: E wave over early mitral diastolic velocity; RV: right ventricle; RVEDA: RV end diastolic area; RVFAC: RV fractional area change; TA S’: 
tricuspid annular systolic velocity; RV FWLS: RV free wall longitudinal strain; and TR: tricuspid regurgitation. *P for trend is based on linear regression using log transformed values of 
AHI. †Significant after adjusting for age, gender, BMI, DM and 24-hour systolic blood pressure.
